[PRESS RELEASE ANNOUNCEMENT
SINGAPORE, 18 December 2025]
Singapore – Verita Neuro are proud to announce a new partnership with Lifeward Ltd. to enhance their world-leading Spinal Cord Injury treatments. Lifeward’s ReWalk® Personal Robotic Exoskeletons will be introduced into Verita Neuro’s intensive rehabilitation programmes at their hospitals in Thailand, Mexico and the United Arab Emirates. For patients, this means access to another innovative, evidence-based rehabilitation device to support Verita Neuro’s pioneering Epidural Stimulation protocol.
Lifeward Inc., a medical technology leader, shares Verita Neuro’s mission to bring the latest innovations out of research labs and directly to patients. Lifeward Inc. specialises in designing, developing and commercialising life-changing solutions for those living with physical disabilities. The ReWalk® Personal Robotic Exoskeleton is designed to support Spinal Cord Injury patients to stand, walk and climb stairs, with customizable settings to support crutch control, walking speed and a smoother gait. The ReWalk® Exoskeleton has been proven to reduce spasticity and improve trunk control, with applications across rehabilitation and daily living.
Verita Neuro’s CEO, Julian Andriesz, commented, “As the global pioneer in neurological restoration, Verita Neuro redefined Epidural Stimulation reconnecting brain-body pathways to regain voluntary movement and vital autonomic functions. We are excited to empower our patients with the most cutting-edge robotic physical rehabilitation systems. Through Lifeward’s ReWalk exoskeleton in our in-patient program, we’re achieving another world first, seamless multimodal enablement.”
The distribution agreement with Verita Neuro represents a new delivery model for Lifeward Inc., marking the first instance of the ReWalk® Exoskeleton being integrated with in-patient training and rehabilitation. The ReWalk® Exoskeleton will be used alongside Verita Neuro’s intensive Spinal Cord Injury treatment protocols, including Epidural Stimulation, LamiSpine and personalized physical therapy.
Verita Neuro has an established international footprint, with the partnership launching across multiple international geographies. Verita Neuro will be the exclusive distributor of ReWalk® initially in Mexico, Thailand, and the United Arab Emirates, where it has advanced centers that offer innovative treatments for people living with a range of neurological conditions. Verita Neuro offers unparalleled reach through its international patient base of over 25,000 spinal cord injury patients plus a growing network of international rehabilitation centers able to deliver highly personalized care.
Mark Grant, CEO of Lifeward said “This latest distribution agreement with Verita Neuro is consistent with Lifeward’s strategy to expand global access to the ReWalk® Personal Exoskeleton for patients with spinal cord injury, building our established distribution and reimbursement presence in the United States and Germany.”
For both Verita Neuro and Lifeward Inc., this partnership is yet another step towards making the very best medical technologies available to the millions living with Spinal Cord Injuries worldwide.
About Verita
Verita Healthcare is a next-generation integrated healthcare group offering precision diagnostics, cutting-edge treatments and advanced Med-Tech solutions. Their healthcare ecosystem has expanded from the Asia Pacific Region to Europe, USA, South America and the Middle East. Wholly owned subsidiary, Verita Neuro, launched in 2015 is a global pioneer in advanced treatments for spinal cord injuries, brain injuries, stroke and other neurological conditions. As the first provider worldwide to offer Epidural Stimulation outside clinical trials, Verita Neuro combines neuromodulation, regenerative therapies and intensive rehabilitation to deliver personalized, life-changing care to patients from over 50 countries.
About Lifeward
Lifeward designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings, as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products, including the ReWalk Exoskeleton, AlterG Anti-Gravity System, ReStore Exo-Suit, and MyoCycle FES System. Founded in 2001, Lifeward has operations in the United States, Israel, and Germany.
Lifeward®, ReWalk®, ReStore®, and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.
